442 related articles for article (PubMed ID: 27485323)
1. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH
Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323
[TBL] [Abstract][Full Text] [Related]
2. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
3. Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5T extremity magnetic resonance imaging? a large cross-sectional study.
Stomp W; Krabben A; van der Heijde D; Huizinga TW; Bloem JL; van der Helm-van Mil AH; Reijnierse M
J Rheumatol; 2014 Aug; 41(8):1630-7. PubMed ID: 25028382
[TBL] [Abstract][Full Text] [Related]
4. Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study.
Burgers LE; Boeters DM; Reijnierse M; van der Helm-van Mil AHM
Arthritis Res Ther; 2018 Apr; 20(1):68. PubMed ID: 29636084
[TBL] [Abstract][Full Text] [Related]
5. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
[TBL] [Abstract][Full Text] [Related]
6. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
[TBL] [Abstract][Full Text] [Related]
7. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort.
Truchetet ME; Dublanc S; Barnetche T; Vittecoq O; Mariette X; Richez C; Blanco P; Mahler M; Contin-Bordes C; Schaeverbeke T;
Arthritis Rheumatol; 2017 Dec; 69(12):2292-2302. PubMed ID: 28853240
[TBL] [Abstract][Full Text] [Related]
8. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
Ten Brinck RM; van Steenbergen HW; van Delft MAM; Verheul MK; Toes REM; Trouw LA; van der Helm-van Mil AHM
Rheumatology (Oxford); 2017 Dec; 56(12):2145-2153. PubMed ID: 28968865
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
[TBL] [Abstract][Full Text] [Related]
10. Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.
van Steenbergen HW; van Nies JA; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
Arthritis Res Ther; 2014 Apr; 16(2):R92. PubMed ID: 24721160
[TBL] [Abstract][Full Text] [Related]
11. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.
Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA
Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484
[TBL] [Abstract][Full Text] [Related]
12. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
[TBL] [Abstract][Full Text] [Related]
13. Sequence of joint tissue inflammation during rheumatoid arthritis development.
Ten Brinck RM; van Steenbergen HW; van der Helm-van Mil AHM
Arthritis Res Ther; 2018 Nov; 20(1):260. PubMed ID: 30463603
[TBL] [Abstract][Full Text] [Related]
14. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
[TBL] [Abstract][Full Text] [Related]
15. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
[TBL] [Abstract][Full Text] [Related]
16. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials.
Aletaha D; Alasti F; Smolen JS
Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354
[TBL] [Abstract][Full Text] [Related]
18. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study.
Ji L; Li G; Xu Y; Zhou W; Zhang Z
Int J Rheum Dis; 2015 Nov; 18(8):859-65. PubMed ID: 25483781
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons.
Mangnus L; Nieuwenhuis WP; van Steenbergen HW; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
Arthritis Res Ther; 2016 Oct; 18(1):245. PubMed ID: 27770823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
